Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oligonucleotide Ligation Assay (OLA) Resistance Study (OLA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Washington
Sponsor:
Collaborators:
Seattle Children's Hospital
University of Nairobi
Information provided by (Responsible Party):
Michael Chung, University of Washington
ClinicalTrials.gov Identifier:
NCT01898754
First received: July 9, 2013
Last updated: May 11, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)